[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607587":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":56,"collaborators":25,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":62,"sex":68,"minAge":69,"maxAge":25,"enrollmentInfo":70,"targetDuration":25,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":80,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University Tunis El Manar","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ginger group","ACTIVE_COMPARATOR","Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy",[13],"Drug: Ginger",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy",[19],"Drug: Placebo",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DRUG","Ginger",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Placebo",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Ibtissem BEN TALEB, M.D.","CONTACT","+216 23 133 748","ibtissem.bentaleb@fmt.utm.tn",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Mohamed Taher Maamouri University Hospital","RECRUITING","Nabeul","Nabeul Governorate","8000","Tunisia","TN",{"type":45,"coordinates":46},"Point",[47,48],10.73763,36.45606,{"lat":48,"lon":47},[51,52],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"name":53,"role":32,"phone":54,"phoneExt":25,"email":55},"Mechaal BEN ALI, M.D.","+216 98 657 034","mechaal_benali@yahoo.fr",{"type":57,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Ben Taleb Ibtissem","Assistant Professor in Anesthesiology and Intensive Care","100607587","phase-4-ginger-to-prevent-nausea-and-vomiting-after-laparoscopic-cholecystectomy-100607587",false,"NCT07190495","Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy","Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial","GINGER-PONV","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Scheduled for elective laparoscopic cholecystectomy under general anesthesia.\n* American Society of Anesthesiologists (ASA) physical status I-III.\n* Able to understand the study procedures and provide written informed consent.\n\nExclusion Criteria:\n\n* Known allergy or hypersensitivity to ginger\n* Documented history of bleeding disorders or current treatment with anticoagulant agents\n* History of severe postoperative nausea and vomiting or an Apfel score of 4\n* Administration of antiemetic drugs or corticosteroids during the preoperative period\n* Pregnancy or breastfeeding\n* Active gastrointestinal or liver disease","ALL","18 Years",{"count":71,"type":72},102,"ESTIMATED","INTERVENTIONAL",[75],"PHASE4","This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.",[78,79],"Postoperative Nausea and Vomiting","Laparoscopic Cholecystectomy",[23,78,79],"2026-04-27",{"date":83,"type":84},"2026-04-28","ACTUAL",{"date":86,"type":84},"2025-07-05",{"date":88,"type":72},"2026-12",{"name":5,"class":6},1]